title: Growth and adrenal androgen status at 7 years in very low birth weight survivors with and without bronchopulmonary dysplasia.
abstract: OBJECTIVE
  To evaluate whether 7 year old VLBW (very low birth weight, <1500 g) survivors with and without bronchopulmonary dysplasia (BPD) evince similar growth status and higher adrenal androgen (AA) levels than term controls, and whether AA levels are higher in VLBW children born small for gestational age (SGA) than in non-SGA cases.
  
  
  METHODS
  Assessment of height standard deviation score (SDs), body mass index (BMI), and serum androstenedione and dehydroepiandrostenedione sulphate levels in 31 VLBW children with BPD, 33 without BPD (no-BPD group), and 33 term controls.
  
  
  RESULTS
  Lower median (range) height SDs was found in BPD (-1.0 (-3.4 to 1.4) SD) and no-BPD (-0.9 (-2.9 to 2.2) SD) children than in term controls (0.3 (-1.5 to 1.9) SD). Low BMI (below 10th centile) was more common in both the BPD (18 (58%)) and no-BPD (16 (49%)) children compared to term cases (3 (9%)). The median (range) androstenedione levels tended to be higher in the BPD (0.8 (0 to 2.8) nmol/l) and no-BPD (0.8 (0 to 2.3) nmol/l) groups than in term controls (0.6 (0 to 1.8)). Higher median (range) dehydroepiandrostenedione sulphate levels were detected in the no-BPD compared to the term group (0.9 (0 to 4.1) v 0.3 (0 to 2.3) micro mol/l). VLBW children born SGA had higher AA levels compared to non-SGA cases.
  
  
  CONCLUSIONS
  At 7 years of age, VLBW children are shorter and tend to have higher AA levels than term controls, but VLBW children with and without BPD do not differ from each other in growth or AA status. Those born SGA have higher AA levels compared to non-SGA cases. The consequences of these findings to final height and to later metabolic and vascular health remain to be determined.
authors.affiliation: Paediatric Research Centre, Medical School, University of Tampere, Finland.
authors.forename: P
authors.initials: P
authors.lastname: Korhonen
authors.forename: E
authors.initials: E
authors.lastname: Hyödynmaa
authors.forename: H-L
authors.initials: HL
authors.lastname: Lenko
authors.forename: O
authors.initials: O
authors.lastname: Tammela
mesh_terms: D000311:Adrenal Glands / Q000378:metabolism; D000728:Androgens / Q000097:blood*; D000735:Androstenedione / Q000097:blood; D001997:Bronchopulmonary Dysplasia / Q000097:blood / Q000503:physiopathology*; D002648:Child; D015331:Cohort Studies; D006130:Growth Disorders / Q000097:blood / Q000209:etiology*; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000254:growth & development*; D019102:Infant, Very Low Birth Weight / Q000254:growth & development*
chemical_list: D000728:Androgens; D000735:Androstenedione